logo

Medivation Inc. (MDVN)



Trade MDVN now with
  Date
  Headline
10/9/2016 7:52:03 AM Astellas Pharma Europe Says XTANDITM? Significantly Improves Time To PSA Progression Versus Placebo
9/28/2016 8:50:50 AM Pfizer Closes Acquisition Of Medivation
9/23/2016 8:32:08 AM Pfizer Reports Expiration Of HSR Waiting Period For Proposed Acquisition Of Medivation
8/22/2016 12:55:56 PM Wedbush Is Cutting Medivation Inc. (MDVN) 2016 Estimate To -1.37 From -1.36
8/22/2016 12:55:24 PM Wedbush Downgrades Medivation Inc. (MDVN) To Neutral From Outperform With $81.50 Up from $66 Price Target
8/22/2016 12:18:14 PM Medivation Holding Onto Standout Gain After Initial Jump
8/22/2016 6:46:11 AM Pfizer To Acquire Medivation For Total Enterprise Value Of Approximately $14 Bln
8/10/2016 8:47:48 AM RBC Capital Markets Is Raising Medivation Inc. (MDVN) Q4 16 Rev. Estimate To 293.5 M From 287.6 M
8/10/2016 8:47:33 AM RBC Capital Markets Is Lowering Medivation Inc. (MDVN) Q3 16 Rev. Estimate To 250.8 M From 251.5 M
8/10/2016 8:47:08 AM RBC Capital Markets Is Cutting Medivation Inc. (MDVN) 2017 Estimate To 1.90 From 2.01
8/10/2016 8:46:55 AM RBC Capital Markets Is Cutting Medivation Inc. (MDVN) 2016 Estimate To 1.34 From 1.37
8/10/2016 8:46:41 AM RBC Capital Markets Is Cutting Medivation Inc. (MDVN) Q4 16 Estimate To 0.54 From 0.56